Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan.
Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan; Department of Ophthalmology, Tokyo Dental College, Tokyo, Japan.
Am J Ophthalmol. 2014 Feb;157(2):311-317.e1. doi: 10.1016/j.ajo.2013.10.019. Epub 2013 Nov 6.
To evaluate the efficacy of a thermosensitive atelocollagen punctal plug in the treatment of dry eye disease.
Prospective observational case series.
The thermosensitive atelocollagen punctal plug was warmed at 37 C, 39 C, 41 C, and 43 C to evaluate the appropriate temperature and time for solidification. Dry eye patients were divided into 2 groups according to the preparation method of the atelocollagen punctal plug. In the conventional implantation group, atelocollagen gel was kept at room temperature for 15 minutes before implantation (27 eyes of 14 patients). In the preheating group, atelocollagen was warmed at 41 C for 8 minutes before implantation (23 eyes of 13 dry eye patients). Strip meniscometry, vital stainings, tear film break-up time (BUT), and symptom scores were evaluated before and 1 month after plug implantation.
In vitro experiments revealed that heating at 41 C for 8 minutes was sufficient to solidify the gel. The mean fluorescein score in the conventional implantation group significantly improved after treatment (before, 3.5 ± 2.3 points; after, 2.5 ± 0.9 points, P < .05). In the preheating group, the mean fluorescein score (before, 3.7 ± 1.7 points; after, 1.5 ± 1.2 points), strip meniscometry (before, 0.6 ± 0.7 mm; after, 1.1 ± 0.3 mm), BUT (before, 3.2 ± 0.7 seconds; after, 4.8 ± 1.0 seconds), and visual analog scale scores (before, 6.6 ± 1.5 points; after, 4.1 ± 0.9 points) significantly improved after treatment (P < .05).
The thermosensitive atelocollagen punctal plug was effective for dry eye treatment. The preheating method was found to be useful to strengthen the efficacy of the thermosensitive atelocollagen punctal plug.
评估热敏性去端肽胶原泪点塞治疗干眼症的疗效。
前瞻性观察性病例系列。
将热敏性去端肽胶原泪点塞在 37°C、39°C、41°C 和 43°C 下加热,以评估凝固的合适温度和时间。根据去端肽胶原泪点塞的制备方法,将干眼症患者分为 2 组。在常规植入组中,去端肽胶原凝胶在植入前于室温下放置 15 分钟(14 例患者的 27 只眼)。在预热组中,去端肽胶原在植入前于 41°C 加热 8 分钟(13 例干眼症患者的 23 只眼)。植入前和植入后 1 个月,进行Strip 棉线法泪液分泌试验、荧光素染色、泪膜破裂时间(BUT)和症状评分。
体外实验表明,加热至 41°C 8 分钟足以使凝胶凝固。常规植入组的平均荧光素评分在治疗后显著改善(治疗前 3.5 ± 2.3 分,治疗后 2.5 ± 0.9 分,P <.05)。在预热组中,平均荧光素评分(治疗前 3.7 ± 1.7 分,治疗后 1.5 ± 1.2 分)、Strip 棉线法泪液分泌试验(治疗前 0.6 ± 0.7mm,治疗后 1.1 ± 0.3mm)、BUT(治疗前 3.2 ± 0.7 秒,治疗后 4.8 ± 1.0 秒)和视觉模拟评分(治疗前 6.6 ± 1.5 分,治疗后 4.1 ± 0.9 分)在治疗后均显著改善(P <.05)。
热敏性去端肽胶原泪点塞治疗干眼症有效。预热法有助于增强热敏性去端肽胶原泪点塞的疗效。